ACTIVITY IN THE THIRD QUARTER OF 2013
ACTIVITY IN THE THIRD QUARTER OF 2013
(Unaudited data)
- CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2013
| thousands of euros | 2012 | 2013 | Variation at current exchange rates | Variation at constant exchange rates |
| France | 233,426 | 252,193 | + 8.0% | + 8.0% |
| International : | 165,959 | 193,077 | + 16.3% | + 18.4% |
| Incl. Europe excluding France | 126,041 | 144,637 | + 14.8% | + 16.3% |
| Incl. North America | 31,282 | 37,732 | + 20.6% | + 24.4% |
| Incl. Other countries | 8,636 | 10,708 | + 24.0% | + 27.4% |
| Group Total | 399,385 | 445,270 | + 11.5% | + 12.3% |
| thousands of euros | 2012 | 2013 | Variation at current exchange rates | Variation at constant exchange rates |
| Non-proprietary Homeopathic Medicines | 213,592 | 225,694 | + 5.7% | + 5.9% |
| OTC Specialties | 185,394 | 219,279 | + 18.3% | + 19.9% |
| Other | 399 | 297 | - 25.6% | - 29.1% |
| Group Total | 399,385 | 445,270 | + 11.5% | + 12.3% |
- DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)
| thousands of euros | 1st Quarter | 2nd Quarter | 3rd Quarter | ||||||
| 2012 | 2013 | Var. 13/12 |
2012 | 2013 | Var. 13/12 |
2012 | 2013 | Var. 13/12 |
|
| France | 74,188 | 84,270 | + 13.6% | 71,210 | 75,327 | + 5.8% | 88,028 | 92,596 | + 5.2% |
| International : | 54,904 | 73,751 | + 34.3% | 41,216 | 42,436 | + 3.0% | 69,839 | 76,890 | + 10.1% |
| Incl. Europe excluding France | 41,807 | 54,334 | + 30.0% | 28,889 | 29,047 | + 0.5% | 55,345 | 61,256 | + 10.7% |
| Incl. North America | 10,285 | 15,562 | + 51.3% | 9,861 | 10,017 | + 1.6% | 11,136 | 12,153 | + 9.1% |
| Incl. Other countries | 2,812 | 3,855 | + 37.1% | 2,466 | 3,372 | + 36.7% | 3,358 | 3,481 | + 3.7% |
| Group Total | 129,092 | 158,021 | + 22.4% | 112,426 | 117,763 | + 4.7% | 157,867 | 169,486 | + 7.4% |
| thousands of euros | 1st Quarter | 2nd Quarter | 3rd Quarter | ||||||
| 2012 | 2013 | Var. 13/12 |
2012 | 2013 | Var. 13/12 |
2012 | 2013 | Var. 13/12 |
|
| Non-proprietary Homeopathic Medicines | 73,427 | 79,062 | + 7.7% | 70,206 | 73,035 | + 4.0% | 69,959 | 73,597 | + 5.2% |
| OTC Specialties | 55,576 | 78,866 | + 41.9% | 42,007 | 44,600 | + 6.2% | 87,811 | 95,813 | + 9.1% |
| Other | 89 | 93 | + 4.5% | 213 | 128 | - 39.9% | 97 | 76 | - 21.6% |
| Group Total | 129,092 | 158,021 | + 22.4% | 112,426 | 117,763 | + 4.7% | 157,867 | 169,486 | + 7.4% |
- HIGHLIGHTS OF THE THIRD QUARTER
Sales revenue in the third quarter 2013 grew by 7.4% compared to 2012 (8.9% at constant rates).
The increase is due to the sales:
- of Non-proprietary Homeopathic Medicines, in particular in France, Italy and the USA.
- of winter Specialties, in particular in France, Italy and Russia.
On September 30, 2013, the group cash balance amounted €116.4 million versus €94.7 million on December 31, 2012.
- OUTLOOK
Considering this performance, Boiron confirms its target of further increases of its business and profitability in 2013.
Our next update: January 23, 2014 at market close, publication of the sales revenue for the year 2013.
Financial information manager: Philippe MONTANT
Contact for financial information: Véronique BOUSCAYROL
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: [email protected]
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at : www.boiron.com
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-33859-cp_boiron-241013.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Source: Actusnews
